CHINARES PHARMA's CR Double-Crane 1Q Net Profit Up 31.96% to RMB244M
2017-04-28,AA Stocks Financial News

CHINARES PHARMA (03320.HK) announced the quarterly report of its subsidiary CR Double-Crane (600062.SH) for three months ended 31 March 2017. During the period, CR Double-Crane’s revenue increased by 6.2% yearly to RMB1.528 billion; net profit surged 31.96% to RMB244 million. (AA Stocks Financial News)2017/04/27